SPARTA Biodiscovery Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.73M

  • Investors
  • 4

SPARTA Biodiscovery General Information

Description

Provider of nanoparticle analytical testing services catering to the pharmaceutical and biotechnology industry. The company offers analytical testing of nanoparticle types used for diagnostic and therapeutic purposes, enabling clients to get simultaneous size and chemical compositional analysis on a single-particle basis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Scale Space White City
  • 58 Wood Lane
  • London W12 7RZ
  • England, United Kingdom
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Diagnostic Equipment
Corporate Office
  • Scale Space White City
  • 58 Wood Lane
  • London W12 7RZ
  • England, United Kingdom

SPARTA Biodiscovery Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SPARTA Biodiscovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 09-Apr-2026 $1.73M Completed Generating Revenue
3. Early Stage VC 16-Jul-2025 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out 01-Jan-2022 Completed Generating Revenue
To view SPARTA Biodiscovery’s complete valuation and funding history, request access »

SPARTA Biodiscovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 36,269 $0.000133 $64.19 $64.19 1x $64.19 18.07%
Ordinary 5,484 $0.000133 $54.54 $54.54 1x $54.54 2.73%
To view SPARTA Biodiscovery’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SPARTA Biodiscovery Patents

SPARTA Biodiscovery Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026132118-A2 Non-contact raman spectroscopy system and methods for using the same Pending 17-Dec-2024
WO-2026132118-A3 Non-contact raman spectroscopy system and methods for using the same Pending 17-Dec-2024
US-12455224-B2 Single particle automated raman trapping analysis Active 19-Jun-2018 G01N15/1434

SPARTA Biodiscovery Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SPARTA Biodiscovery Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Providence Investment Company Venture Capital Minority
Sartorius Corporation Minority
Imperial College London University
Imperial Enterprise Lab Accelerator/Incubator
To view SPARTA Biodiscovery’s complete investors history, request access »

SPARTA Biodiscovery FAQs

  • When was SPARTA Biodiscovery founded?

    SPARTA Biodiscovery was founded in 2022.

  • Where is SPARTA Biodiscovery headquartered?

    SPARTA Biodiscovery is headquartered in London, United Kingdom.

  • What is the size of SPARTA Biodiscovery?

    SPARTA Biodiscovery has 12 total employees.

  • What industry is SPARTA Biodiscovery in?

    SPARTA Biodiscovery’s primary industry is Discovery Tools (Healthcare).

  • Is SPARTA Biodiscovery a private or public company?

    SPARTA Biodiscovery is a Private company.

  • What is the current valuation of SPARTA Biodiscovery?

    The current valuation of SPARTA Biodiscovery is .

  • What is SPARTA Biodiscovery’s current revenue?

    The current revenue for SPARTA Biodiscovery is .

  • How much funding has SPARTA Biodiscovery raised over time?

    SPARTA Biodiscovery has raised $6.79M.

  • Who are SPARTA Biodiscovery’s investors?

    Providence Investment Company, Sartorius, Imperial College London, and Imperial Enterprise Lab have invested in SPARTA Biodiscovery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process